Relapse of hepatitis C in three immunocompetent patients achieved a sustained virological response following interferon-based antiviral therapy

被引：0
|
作者：
Ji, Fanpu [1 ]
Cai, Zhifang [1 ]
Deng, Hong [1 ]
机构：
[1] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Infect Dis, Xian 710049, Peoples R China
来源：
JOURNAL OF CLINICAL VIROLOGY | 2013年 / 58卷 / 03期
关键词：
RIBAVIRIN; VIRUS; COMBINATION; DURABILITY;
D O I：
10.1016/j.jcv.2013.08.026
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：590 / 591
页数：2
相关论文
共 50 条
  • [41] Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
    Chang, K-C
    Wu, Y-Y
    Hung, C-H
    Lu, S-N
    Lee, C-M
    Chiu, K-W
    Tsai, M-C
    Tseng, P-L
    Huang, C-M
    Cho, C-L
    Chen, H-H
    Hu, T-H
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2481 - 2488
  • [42] Prospective Study of Withdrawal of Antiviral therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response
    Gara, Naveen
    Tana, Michele M.
    Kattapuram, Meera
    Auh, Sungyoung
    Sullivan, Lauren
    Fryzek, Nancy
    Walter, Mary
    Umarova, Regina
    Zhao, Xiongce
    Cloherty, Gavin
    Doo, Edward
    Heller, Theo
    Liang, T. Jake
    Ghany, Marc G.
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (11) : 1888 - 1900
  • [43] Predictive Value of Complete and Partial Early Virological Response on Sustained Virological Response Rates of Genotype-4 Chronic Hepatitis C Patients Treated with PEG-Interferon plus Ribavirin
    Elefsiniotis, I. S.
    Vezali, E.
    Mihas, C.
    Saroglou, G.
    INTERVIROLOGY, 2009, 52 (05) : 247 - 251
  • [44] Predictor factors of sustained virological response in patients with chronic hepatitis C treated with current direct-acting antiviral drugs
    Soliman, Elwy M. K.
    Morsy, Hisham A. A.
    Othman, Ashraf M. M.
    Mady, Ahmed M.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (09) : 2015 - 2020
  • [45] Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
    Itose, Ichiyo
    Kanto, Tatsuya
    Inoue, Michiyo
    Miyazaki, Masanori
    Miyatake, Hideki
    Sakakihara, Mitsuru
    Yakushijin, Takayuki
    Oze, Tsugiko
    Hiramatsu, Naoki
    Takehara, Tetsuo
    Kasahara, Akinori
    Katayama, Kazuhiro
    Kato, Michio
    Hayashi, Norio
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (05) : 511 - 521
  • [46] Treatment of chronic hepatitis c with consensus interferon in relapsers and non-responders to interferon-based therapy
    Steffen, M.
    Cornberg, M.
    Buggisch, P.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2368 - 2372
  • [47] New-onset of celiac disease during interferon-based therapy for hepatitis C
    Vasudevan, Abhinav
    Lubel, John S.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 83 - 85
  • [48] Sustained Virological Response and Baseline Predictors in HIV-HCV Coinfected Patients Retreated with Pegylated Interferon and Ribavirin after Failing a Previous Interferon-Based Therapy: Systematic Review and Meta-Analysis
    Basso, Monica
    Parisi, Saverio Giuseppe
    Mengoli, Carlo
    Gentilini, Valeria
    Menegotto, Nicola
    Monticelli, Jacopo
    Nicole, Stefano
    Cruciani, Mario
    Palu, Giorgio
    HIV CLINICAL TRIALS, 2013, 14 (04): : 127 - 139
  • [49] Efficacy of oral combination antiviral therapy in genotype 4 hepatitis C infection and the importance of rapid virological response
    Altinkaya, Engin
    Aktas, Ahmet
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (01) : 151 - 157
  • [50] Hepatitis C "true" late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy
    Klag, Thomas
    Dietz, Julia
    Werner, Christoph R.
    Schwarz, Julia M.
    Lauer, Ulrich M.
    Beck, Robert
    Malek, Nisar P.
    Sarrazin, Christoph
    Berg, Christoph P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (04) : 862 - 863
12345